PharmiWeb.com - Global Pharma News & Resources

Reports - Press Releases

Date Title Company
21-May-2025 Jaguar Health Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules ACCESS Newswire
21-May-2025 Protagonist Therapeutics to Participate in the Jefferies Global Healthcare Conference 2025 ACCESS Newswire
21-May-2025 Moderna Provides Update on BLA Submission for Combination Vaccine Against Influenza and COVID-19 ACCESS Newswire
21-May-2025 Regenerative Medical Technologies Group Increases Q1 2025 Sales By 67% Over Q1 2024 and Achieves Operating Profit for the Quarter of $134,000 ACCESS Newswire
21-May-2025 Zomedica Launches Enhanced Equine Insulin Assay for the TRUFORMA(R) Diagnostic Platform Featuring an Extended Range and Automatic Sample Dilution ACCESS Newswire
21-May-2025 PPN Expands Influence in Pharmacy Media with New Hosting Platform and June Podcast Lineup ACCESS Newswire
21-May-2025 Faron Appoints Ralph Hughes as Chief Business Officer (CBO) ACCESS Newswire
21-May-2025 ReproNovo Raises $65 Million Series A Financing to Advance Phase 2 Clinical Trials of Novel Therapies in Reproductive Medicine and Women’s Health ACCESS Newswire
20-May-2025 KARE PharmTech Acquires Nuehee Healthcare Platform ACCESS Newswire
20-May-2025 The Radiology Group Atlanta Calls for a Human-First Approach to Tele-Radiology ACCESS Newswire
20-May-2025 Javid Javdani Calls for Stronger Community-Centred Businesses in Multicultural Cities ACCESS Newswire
20-May-2025 Dr. Todd H. Lanman and Dr. Jared Ament Perform First-Ever Combined Implantation of MOTUS Device and TOPS(TM) System at Adjacent Lumbar Levels ACCESS Newswire
20-May-2025 University of Edinburgh launches UK-first innovation initiative University of Edinburgh
20-May-2025 OKYO Pharma to Present at the GPCRs-Targeted Drug Discovery Summit OKYO Pharma
20-May-2025 SISCAPA and Biognosys Announce Strategic Collaboration to Deliver End-to-End High-Sensitivity Targeted Protein Quantification Solutions Siscapa
20-May-2025 Transactions in Connection with Share Buy-back Program Genmab
20-May-2025 Cristcot Appoints Jenny Gizzi as Chief Administrative Officer Cristcot
20-May-2025 VERAXA Biotech Appoints Rick Austin as Chief Scientific Officer Veraxa Biotech
20-May-2025 Poolbeg Pharma plc announces FY2024 Results and Proposed Fundraising to raise approximately £4.1 million Poolbeg Pharma PLC
20-May-2025 First Patient Randomized in Jaguar Health's Phase 2 Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Crofelemer in Pediatric Patients with Microvillus Inclusion Disease (MVID) ACCESS Newswire